Across TCGA pan-cancer cohorts, NMNAT1P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NMNAT1P2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where NMNAT1P2 RNA is repressed in tumor relative to normal tissue. In most cancer types NMNAT1P2 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC and KICH are the cancer types where NMNAT1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NMNAT1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.005	.024	3	view →
KICH	All	All	−0.017	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NMNAT1P2 RNA expression & survival · all NMNAT1P2 data types